News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
560,585 Results
Type
Article (47167)
Company Profile (118)
Press Release (513285)
Multimedia
Podcasts (164)
Webinars (22)
Section
Business (145953)
Career Advice (2427)
Deals (28189)
Drug Delivery (163)
Drug Development (68695)
Employer Resources (160)
FDA (16101)
Job Trends (12096)
News (266086)
Policy (29936)
Tag
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (3)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (5)
Academia (2344)
Academic (1)
Accelerated approval (53)
Adcomms (40)
Allergies (161)
Alliances (36144)
ALS (203)
Alzheimer's disease (1838)
Antibody-drug conjugate (ADC) (457)
Approvals (16355)
Artificial intelligence (643)
Autoimmune disease (299)
Automation (46)
Bankruptcy (313)
Best Places to Work (9195)
BIOSECURE Act (23)
Biosimilars (223)
Biotechnology (68)
Bladder cancer (199)
Brain cancer (69)
Breast cancer (703)
Cancer (5570)
Cardiovascular disease (488)
Career advice (2065)
Career pathing (46)
CAR-T (302)
CDC (76)
Celiac Disease (2)
Cell therapy (873)
Cervical cancer (46)
Clinical research (60167)
Collaboration (1813)
Company closure (7)
Compensation (1410)
Complete response letters (102)
COVID-19 (2753)
CRISPR (106)
C-suite (1056)
Cystic fibrosis (150)
Data (7533)
Decentralized trials (3)
Denatured (36)
Depression (179)
Dermatology (86)
Diabetes (558)
Diagnostics (5753)
Digital health (45)
Diversity (7)
Diversity, equity & inclusion (43)
Drug discovery (285)
Drug pricing (239)
Drug shortages (34)
Duchenne muscular dystrophy (297)
Earnings (64219)
Editorial (77)
Employer branding (20)
Employer resources (142)
Events (84159)
Executive appointments (994)
FDA (19816)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (18)
Frontotemporal dementia (32)
Funding (1504)
Gene editing (233)
Generative AI (57)
Gene therapy (734)
GLP-1 (1163)
Government (4276)
Grass and pollen (8)
Guidances (396)
Healthcare (15025)
HIV (82)
Huntington's disease (60)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (103)
Immunology and inflammation (335)
Immuno-oncology (91)
Indications (179)
Infectious disease (3086)
Inflammatory bowel disease (211)
Inflation Reduction Act (14)
Influenza (125)
Intellectual property (276)
Interviews (457)
IPO (14158)
IRA (58)
Job creations (3177)
Job search strategy (1676)
JPM (69)
Kidney cancer (21)
Labor market (102)
Layoffs (639)
Leadership (49)
Legal (7022)
Liver cancer (99)
Longevity (25)
Lung cancer (723)
Lymphoma (408)
Machine learning (56)
Management (52)
Manufacturing (975)
MASH (199)
Medical device (11733)
Medtech (11844)
Mergers & acquisitions (15184)
Metabolic disorders (1564)
mRNA (235)
Multiple sclerosis (171)
NASH (23)
Neurodegenerative disease (430)
Neuropsychiatric disorders (118)
Neuroscience (3333)
Neurotech (2)
NextGen: Class of 2026 (5000)
Non-profit (3206)
Now hiring (34)
Obesity (781)
Opinion (307)
Ovarian cancer (207)
Pain (238)
Pancreatic cancer (299)
Parkinson's disease (361)
Partnered (26)
Patents (576)
Patient recruitment (645)
Peanut (59)
People (44896)
Pharmaceutical (34)
Pharmacy benefit managers (34)
Phase 1 (18061)
Phase 2 (26073)
Phase 3 (21291)
Pipeline (8465)
Policy (380)
Postmarket research (2212)
Preclinical (7355)
Press Release (28)
Prostate cancer (310)
Psychedelics (65)
Radiopharmaceuticals (293)
Rare diseases (1136)
Real estate (4314)
Recruiting (65)
Regulatory (24154)
Reports (48)
Research institute (2139)
Resumes & cover letters (405)
Rett syndrome (39)
RNA editing (22)
RSV (83)
Schizophrenia (184)
Series A (260)
Series B (196)
Service/supplier (8)
Sickle cell disease (113)
Special edition (30)
Spinal muscular atrophy (149)
Sponsored (52)
Startups (2816)
State (1)
Stomach cancer (21)
Supply chain (127)
Tariffs (104)
The Weekly (126)
Vaccines (1190)
Venture capital (119)
Weight loss (552)
Women's health (109)
Worklife (24)
Date
Today (108)
Last 7 days (483)
Last 30 days (3191)
Last 365 days (28382)
2026 (12388)
2025 (28393)
2024 (31393)
2023 (34979)
2022 (45062)
2021 (48495)
2020 (45510)
2019 (36209)
2018 (27392)
2017 (27803)
2016 (25802)
2015 (27972)
2014 (21774)
2013 (17791)
2012 (18963)
2011 (19381)
2010 (17504)
Location
Africa (691)
Alabama (74)
Alaska (6)
Arizona (271)
Arkansas (12)
Asia (32772)
Australia (5764)
California (12437)
Canada (2917)
China (1119)
Colorado (484)
Connecticut (553)
Delaware (375)
Europe (80438)
Florida (1889)
Georgia (383)
Hawaii (4)
Idaho (40)
Illinois (918)
India (75)
Indiana (498)
Iowa (23)
Japan (520)
Kansas (111)
Kentucky (36)
Louisiana (31)
Maine (77)
Maryland (1502)
Massachusetts (8958)
Michigan (301)
Minnesota (646)
Mississippi (5)
Missouri (133)
Montana (13)
Nebraska (23)
Nevada (131)
New Hampshire (64)
New Jersey (3304)
New Mexico (16)
New York (3196)
North Carolina (1578)
North Dakota (8)
Northern California (6344)
Ohio (341)
Oklahoma (17)
Oregon (34)
Pennsylvania (2365)
Puerto Rico (22)
Rhode Island (33)
South America (1047)
South Carolina (83)
South Dakota (2)
Southern California (4892)
Tennessee (182)
Texas (1905)
United States (43220)
Utah (310)
Virginia (300)
Washington D.C. (73)
Washington State (967)
West Virginia (4)
Wisconsin (127)
Wyoming (1)
560,585 Results for "urogene s a".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
UroGen Pharma to Present at Upcoming May 2026 Investor Conferences
May 7, 2026
·
1 min read
Press Releases
UroGen Pharma to Report First Quarter 2026 Financial Results on Wednesday, May 6th, 2026
April 29, 2026
·
1 min read
Press Releases
UroGen Reports ZUSDURI™ Revenue More Than Doubled Quarter-over-Quarter and Provides First Quarter 2026 Financial Results and Highlights
May 6, 2026
·
22 min read
Press Releases
UroGen Pharma to Present at the Guggenheim Securities Emerging Outlook: Biotech Summit
February 4, 2026
·
1 min read
Press Releases
UroGen Pharma to Present at the TD Cowen 46th Annual Health Care Conference
February 25, 2026
·
1 min read
Press Releases
UroGen Reports 94.5% Six-Month Duration of Response in Phase 3 UTOPIA Trial, Advancing UGN-103 Toward Potential Approval in Recurrent Low-Grade Intermediate-Risk NMIBC
May 15, 2026
·
12 min read
Press Releases
UroGen Launches LG-UTUC Luminaries Initiative Recognizing Excellence and Leadership in Treatment of Patients with Low-Grade Upper Tract Urothelial Cancer
April 8, 2026
·
3 min read
Bladder cancer
UroGen’s Bladder Cancer Drug Wins FDA Approval Over Adcomm’s Objections
The FDA’s Oncologic Drugs Advisory Committee narrowly voted against the approval of Zusduri, citing the lack of a completely randomized study to back up the application.
June 13, 2025
·
2 min read
·
Tristan Manalac
Press Releases
UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - March 6, 2026
March 9, 2026
·
2 min read
Press Releases
UroGen Announces ZUSDURI™ Launch is On-Track and Reports Fourth Quarter and Full Year 2025 Financial Results
March 2, 2026
·
22 min read
1 of 56,059
Next
